Dr Lalchand. Lab

DRLALCHANDANILABS16 May 2024
Healthcare
0.00 (0.00%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Dr Lalchand. Lab
Dr Lalchand. Lab
Healthcare
DRLALCHANDANILABS16 May 2024
0.00 (0.00%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Dr Lalchand. Lab - Share Price & Details

Lowest Today
20
Highest Today
21.9
Today’s Open
20
Prev. Close
21.9
52 Week High
35
52 Week Low
15.68
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
-10.32%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
1.07
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Price Performance

4.29 %
1 Wk
5.09 %
1 M
5.04 %
3 M
-10.32 %
1 Y
0.00 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Dr Lalchandani Labs Ltd
₹21.90(0.00/0.00%)
21.90+0.009.49-10.320.001.07
Kovai Medical Center & Hospital Ltd
₹4,066.85(+32.65/0.81%)
4,066.85+32.654,449.13102.7328.145.70
34.34-0.6225.6569.3395.39143.87
Shree Pacetronix Ltd
₹217.00(+6.00/2.84%)
217.00+6.0078.1150.1719.966.89
Fortis Malar Hospitals Ltd
₹70.06(-1.42/-1.99%)
70.06-1.42131.3037.910.002.30
Apollo Hospitals Enterprise Ltd
₹5,956.95(+4.90/0.08%)
5,956.95+4.9085,651.8034.0785.7711.74

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Ltd is in the Healthcare sector, having a market capitalization of Rs. 9.49 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes Arjan Lalchandani, Arjan Lalchandani,Mohit Lalchandani,Anchal Gupta,Rajiv Handa,Prakash Jhuraney,Swati Chandra (Dr Lalchandani Labs Ltd) among others.
Chairman
Arjan Lalchandani
Registered office
M-20 Basement,Greater Kailash-1,New Delhi,New Delhi,110048
FAX :
Background
Incorporation Year2017
Face Value₹10
Market Lot4000

Latest News

Trade setup for Tuesday: 15 things to know before opening bell
Before market opens on Tue, check these things:
📌Key Levels For The Nifty 50
📌Key Levels For The Bank Nifty
📌Nifty Call Options Data
📌Nifty Put Options Data
📌Bank Nifty Call Options Data
📌Bank Nifty Put Options Data
📌Put-Call Ratio
📌India VIX
📌Long Unwinding (31 Stocks)
📌 Short Build-up (30 Stocks)
📌Short-Covering (57 Stocks)
📌 High Delivery Trades
📌Stocks Under F&O Ban
20 May 2024 | 07:29 PM
Trade setup for Tuesday: 15 things to know before opening bell
Before market opens on Tue, check these things:
📌Key Levels For The Nifty 50
📌Key Levels For The Bank Nifty
📌Nifty Call Options Data
📌Nifty Put Options Data
📌Bank Nifty Call Options Data
📌Bank Nifty Put Options Data
📌Put-Call Ratio
📌India VIX
📌Long Unwinding (31 Stocks)
📌 Short Build-up (30 Stocks)
📌Short-Covering (57 Stocks)
📌High Delivery Trades
📌Stocks Under F&O Ban.
20 May 2024 | 07:29 PM
IRIS Business S Consolidated March 2024 Net Sales at Rs 30.35 crore
Reported Consolidated quarterly numbers for IRIS Business Services are:Net Sales at Rs 30.35 crore in March 2024 up 47.66% from Rs. 20.56 crore in March 2023.Quarterly Net Profit at Rs. 4.71 crore in March 2024 up 197.45% from Rs. 1.58 crore in March 2023.EBITDA stands at Rs. 6.66 crore in March 2024 up 96.46% from Rs. 3.39 crore in March 2023.
20 May 2024 | 11:55 PM
JB Pharma aims 12-14% revenue growth over next 2 years: CEO
JB Pharma, majority-owned by investment firm KKR & Co., aims to grow its revenue by 12-14% in the next couple of years with a thrust on domestic and contract development and manufacturing organization (CDMO) businesses, its chief executive Nikhil Chopra said. The company is also foraying into new geographies like Europe and Brazil through tie-ups and product launches.
20 May 2024 | 08:17 PM
Hindustan Aeronautics Consolidated March 2024 Net Sales at Rs 14,768.75 cr
Reported Consolidated quarterly numbers for Hindustan Aeronautics are: Net Sales at Rs 14,768.75 crore in March 2024 up 18.2% from Rs. 12,494.67 crore in March 2023.Quarterly Net Profit at Rs. 4,308.71 crore in March 2024 up 52.19% from Rs. 2,831.18 crore in March 2023. EBITDA stands at Rs. 6,458.57 crore in March 2024 up 62.77% from Rs. 3,968.02 crore in March 2023.
20 May 2024 | 08:02 PM

How to buy Dr Lalchand. Lab shares on nse?

To buy Dr Lalchand. Lab shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Dr Lalchand. Lab share price today?

The Dr Lalchand. Lab shares price on nse is Rs.21.9 today.

What is the market cap of Dr Lalchand. Lab shares on BSE ?

The company has a market capitalization of Rs.9.49Cr

What is the PE & PB ratio of Dr Lalchand. Lab shares ?

PE is 0 and PB is 1.07

What is the 52 Week High and Low of Dr Lalchand. Lab shares?

Dr Lalchand. Lab stock price high: Rs.35 Dr Lalchand. Lab stock price low: Rs.15.68